OC
LLY icon

Opinicus Capital’s Eli Lilly LLY Stock Holding History

Opinicus Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.8M Sell
3,999
-20
-0.5% -$20.4K 2.57% 11
2026
Q1 		$3.7M Sell
4,019
-12
-0.3% -$12.2K 2.61% 11
2025
Q4 		$4.33M Sell
4,031
-303
-7% -$290K 3.02% 8
2025
Q3 		$3.31M Buy
4,334
+738
+21% +$549K 2.29% 10
2025
Q2 		$2.8M Buy
3,596
+101
+3% +$78.5K 2.13% 10
2025
Q1 		$2.89M Sell
3,495
-129
-4% -$107K 2.55% 9
2024
Q4 		$2.8M Sell
3,624
-83
-2% -$68.7K 2.35% 10
2024
Q3 		$3.28M Buy
3,707
+61
+2% +$54.8K 2.63% 9
2024
Q2 		$3.3M Buy
3,646
+21
+0.6% +$16.8K 2.78% 9
2024
Q1 		$2.82M Buy
3,625
+40
+1% +$28.5K 2.5% 9
2023
Q4 		$2.09M Buy
+3,585
New +$2.09M 2.13% 11

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Opinicus Capital's LLY Position: Q2 2026 in Review

Opinicus Capital reduced its Eli Lilly (LLY) stake by 0.5% in Q2 2026, selling an estimated $20.4K and leaving 3,999 shares worth $4.8M. The position accounts for 2.57% of the portfolio, ranked #11.

Opinicus Capital first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Opinicus Capital held 3,999 shares of Eli Lilly worth $4.8M as of Q2 2026.
  • Opinicus Capital sold 20 Eli Lilly shares in Q2 2026, an estimated $20.4K.
  • Eli Lilly made up 2.57% of Opinicus Capital's portfolio in Q2 2026, its #11 holding.
  • Opinicus Capital first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Opinicus Capital's 13F filing for Q2 2026, filed 27 Jul 2026.